Document Detail

Antigen-specific therapeutic approaches in Type 1 diabetes.
MedLine Citation:
PMID:  22355799     Owner:  NLM     Status:  MEDLINE    
Development of strategies capable of specifically curbing pathogenic autoimmune responses in a disease- and organ-specific manner without impairing foreign or tumor antigen-specific immune responses represents a long sought-after goal in autoimmune disease research. Unfortunately, our current understanding of the intricate details of the different autoimmune diseases that affect mankind, including type 1 diabetes, is rudimentary. As a result, progress in the development of the so-called "antigen-specific" therapies for autoimmunity has been slow and fraught with limitations that interfere with bench-to-bedside translation. Absent or incomplete understanding of mechanisms of action and lack of adequate immunological biomarkers, for example, preclude the rational design of effective drug development programs. Here, we provide an overview of antigen-specific approaches that have been tested in preclinical models of T1D and, in some cases, human subjects. The evidence suggests that effective translation of these approaches through clinical trials and into patients will continue to meet with failure unless detailed mechanisms of action at the level of the organism are defined.
Xavier Clemente-Casares; Sue Tsai; Carol Huang; Pere Santamaria
Related Documents :
2325579 - Demonstration of a surface antigen of clostridium tyrobutyricum by use of immunoblottin...
22208979 - Simplified synthetic antibody libraries.
22907369 - Affinity maturation by semi-rational approaches.
2052359 - Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
3621559 - Monoclonal and polyclonal antibodies compared for radioimmunoassay of somatomedin-c in ...
1890189 - Immunologic characterization and specificity of three monoclonal antibodies against the...
10875759 - Antibody responses to sheep red blood cell and brucella abortus antigens in a turkey li...
225959 - Antigenic analyses of two axenized strains of entamoeba histolytica by two-dimensional ...
1280879 - Immunostimulants added to injected aeromonas salmonicida bacterin enhance the defense m...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Cold Spring Harbor perspectives in medicine     Volume:  2     ISSN:  2157-1422     ISO Abbreviation:  Cold Spring Harb Perspect Med     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-22     Completed Date:  2013-06-17     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  101571139     Medline TA:  Cold Spring Harb Perspect Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  a007773     Citation Subset:  IM    
Julia McFarlane Diabetes Research Centre, University of Calgary, NW Calgary, Alberta T2N 4N1, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens / therapeutic use*
Chaperonin 60 / therapeutic use
Clinical Trials as Topic
Dendritic Cells / immunology
Diabetes Mellitus, Type 1 / therapy*
Disease Models, Animal
Drug Evaluation
Enzyme Inhibitors / therapeutic use
Glutamate Decarboxylase / antagonists & inhibitors
Hypoglycemic Agents / therapeutic use
Immunotherapy / methods*
Insulin / therapeutic use
Vaccines, DNA / therapeutic use
Grant Support
//Canadian Institutes of Health Research
Reg. No./Substance:
0/Antigens; 0/Chaperonin 60; 0/Enzyme Inhibitors; 0/Hypoglycemic Agents; 0/Insulin; 0/Vaccines, DNA; EC Decarboxylase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Microbicides: topical prevention against HIV.
Next Document:  The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes.